[Skip to Navigation]
February 1966

Therapy of Laryngeal Cancer

Author Affiliations

From the Department of Otolaryngology, College of Medicine of the University of Illinois, Chicago.

Arch Otolaryngol. 1966;83(2):92-104. doi:10.1001/archotol.1966.00760020094004

PROGRESS in the treatment of cancer of the larynx has been continuous, with several milestones, some detours, but in general, a progressive accumulation of concepts of both the clinical nature of the disease and of its management. It is, in fact, a paradox that there has been any significant progress when the underlying disease or conditions that comprise human cancer are so poorly understood.

Fundamentally, the therapeutic modalities remain status quo, namely: extirpation or destruction of tumor-bearing tissues. It is the awareness of the shortcomings that has served as a stimulus for seeking improvement in management. The background of experience has become a basis in pyramiding manner for evaluation and reevaluation, and the basis from which the ground rules for current therapy have evolved.

The history of the development and the application of the modalities of therapy for cancer of the larynx had its inception during the period 1860 to

Add or change institution